DePuy Synthes Rolls Out TriLEAP Lower Extremity Plates

DePuy Synthes, a Johnson & Johnson MedTech company, has launched its TriLEAP lower extremity anatomic plating system.
 
The low-profile, procedure-specific titanium plates for foot and ankle surgeries received U.S. Food and Drug Administration (FDA) 510(k) clearance for forefoot, midfoot, and hindfoot elective and trauma procedures in October 2023.
 
TriLEAP features contoured and conventional titanium plates that accommodate various screw shaft options to allow for rescue screws. The system also touts color-coded instrumentation with ease-of-use features, according to DePuy Synthes.
 
Foot and ankle plating systems are used in procedures such as bunionectomies, osteotomies, fusions, and fractures of the foot or ankle.
 
According to Dr. Michael Campbell, M.D., FAAOS, board certified orthopedic surgeon with Atlantic Orthopaedic Specialists who specializes in conditions of the foot and ankle, there’s a growing need for plating systems that have greater precision and customization because foot and ankle anatomy varies widely among patients.
 
“…having plates that can adapt more precisely to individual anatomy can lead to better outcomes,” Dr. Campbell told the press. “I’m excited that the TriLEAP System is now available for first ray surgery and foot and ankle reconstruction. The complete and specific set of tools for different procedures means we have a system that truly meets the diverse demands of the operating room, helping us provide even better care for our patients.”
 
DePuy Synthes plans to feature the TriLEAP system at next month’s American Orthopaedic Foot and Ankle Society (AOFAS) annual meeting.
 
“With the launch of the TriLEAP System, we now have a comprehensive portfolio for first ray surgery, which addresses conditions of the big toe, first toe bone, and foot and ankle reconstruction,” said Oray Boston, Worldwide President, DePuy Synthes Trauma, Extremities, Craniomaxillofacial, Animal Health and Sports. “This product is key to our strategy, which is to help advance our forefoot and midfoot portfolio to get people back on their feet. It also builds on our established orthopedics leadership and takes us further in our goal to lead in foot and ankle care.”